Destiny Pharma Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Destiny Pharma in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Destiny Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Destiny Pharma | - | - | - | - | - | - | - |
| Proteome Sciences | 2.940% | 2.941% | 6.061% | -46.154% | -6.667% | -33.333% | 311.765% |
| Oxford BioMedica PLC | -0.910% | -1.351% | 13.472% | 32.727% | 79.508% | -74.083% | -25.256% |
| Sareum Holdings plc | 2.860% | 2.857% | -15.294% | -68.696% | -53.171% | -91.887% | - |
News
Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula
Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula
Destiny Pharma initiates research to explore XF drug potential for CF
Destiny Pharma initiates research to explore XF drug potential for CF